Clinical Trial Update: Hypofractionated Radiotherapy for Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hypofractionated radiotherapy for soft tissue sarcoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING